Science

They're Spending $93 Billion to Fly to the Moon and Won't Even Land — Here's Why Artemis II Is Not Just Expensive Tourism

Summary

Humans are heading back to the Moon's orbit for the first time in 53 years. Artemis II, set to launch April 1, is just a 10-day flyby with no landing — yet this single mission carries the weight of the US-China space rivalry, the justification for $93 billion in spending, and humanity's shot at becoming a multi-planetary species.

Key Points

1

First crewed lunar flight in 53 years launches April 1

For the first time since Apollo 17 in 1972, humans will reach the Moon's vicinity. Four astronauts aboard the Orion spacecraft will fly for 10 days, approaching within 6,513 km of the far side. This mission is the critical gateway to validate Orion's life support, communications, radiation shielding, and thermal control systems with real human lives at stake. Without this validation, Artemis III's lunar landing is impossible. Rollout to the launch pad is scheduled for March 20, with a launch window of April 1-6. After three postponements due to helium leaks, NASA has nowhere left to retreat.

2

The crew deliberately shatters Apollo's narrative

Victor Glover becomes the first person of color to reach deep space. Christina Koch becomes the first woman. Canada's Jeremy Hansen becomes the first non-American to orbit the Moon. Commander Reid Wiseman rounds out a foursome that intentionally breaks Apollo's white American men's club image. This isn't diversity marketing — it's the physical embodiment of the Artemis Accords framework signed by 55 nations, with allied nations like Canada (Canadarm3 robotic arm) and ESA (Orion service module) providing core mission components.

3

SLS is a $4 billion-per-launch anachronistic rocket

SLS development cost $29 billion ($35.4 billion inflation-adjusted), with over $93 billion spent on the entire Artemis program. At $4 billion per launch, while SpaceX targets under $100 million for Starship, the cost is unsustainable. NASA's own senior officials admitted to the GAO that current cost levels are unaffordable, and the OIG called the 50% cost reduction goal highly unrealistic. The February 2026 cancellation of Block 1B/2 upgrades signals NASA is finally facing reality, but SLS may be retired after Artemis III.

4

The Moon has become a resource battleground, not a science destination

Permanently shadowed craters at the lunar South Pole contain significant water ice deposits. This water can be split into hydrogen and oxygen for rocket fuel, making the Moon a potential refueling station for Mars missions. Helium-3, useful for nuclear fusion, is also abundant on the lunar surface. The US has built a 55-nation Artemis Accords coalition while China is constructing a rival bloc with 13 ILRS partner nations including Russia. The geopolitical balance of the late 21st century may be determined at lunar South Pole craters.

5

Artemis II success opens the era of public-private space exploration

Artemis III will use SpaceX Starship as the lunar lander — an unprecedented depth of public-private cooperation. NASA provides the rocket and command module, SpaceX the lander, ESA the service module, and Canada the robotic arm. Artemis II must succeed for this model's first validation to be complete. Failure would shake confidence in the public-private model itself and intensify Congressional pressure for budget cuts.

Positive & Negative Analysis

Positive Aspects

  • 53-year milestone in international cooperative lunar exploration

    While Apollo was a US-only project, Artemis is a 55-nation framework. Canada (Canadarm3), ESA (Orion service module), Japan, and Australia are making core contributions, enabling cost-sharing and technology exchange. If this model succeeds, the same framework can be applied to Mars exploration. The international cooperation experience on the Moon could become the prototype governance model for humanity's multi-planetary transition.

  • Validation of a new public-private paradigm

    The structure where NASA (government) handles the launch vehicle and command module while SpaceX (private) provides the lunar lander is unprecedented in space exploration history. As SLS faces cost criticism, SpaceX Starship's low-cost launch capability joining from Artemis III could dramatically improve the program's cost efficiency. This marks the end of NASA building everything alone and a qualitative transformation of the space industry ecosystem.

  • Accumulation of deep space crewed flight data

    For over 50 years since Apollo, humans have not ventured beyond low Earth orbit (ISS). The data Artemis II collects on radiation exposure, life support performance, communication delays, and astronaut physiological responses in deep space will form the foundational dataset for all future lunar and Mars crewed missions.

  • Next-generation inspiration and STEM pipeline

    The under-16 generation has never experienced human lunar flight. Artemis II's live broadcast will make space feel real for millions, stimulating STEM workforce entry. Just as the Apollo generation was inspired to drive the semiconductor, computer, and internet revolutions, the innovations the Artemis generation will create remain an exciting prospect.

  • SLS rationalization reduces risk

    The February 2026 Block 1B/2 cancellation shows NASA has woken up from endless upgrade dreams to take a realistic path. Standardizing on proven Block 1 systems while buying time for the transition to next-generation vehicles like Starship is a strategic judgment to deliver results with certainty rather than invest in uncertain futures.

Concerns

  • Unsustainable $4 billion per launch cost structure

    SLS launch costs are 40 times SpaceX Starship's target. Development costs of $29 billion and total program costs of $93 billion test Congressional and taxpayer patience. NASA itself admits current cost levels are unsustainable, and the 50% cost reduction goal was deemed highly unrealistic by auditors.

  • A decade of delays eroding strategic advantage

    What was supposed to launch in 2016 has been pushed back 10 years. Artemis II alone was postponed three times. Meanwhile, China successfully returned lunar surface samples with Chang'e 5 and collected far-side samples with Chang'e 6, steadily marching toward a 2030 crewed landing. Time is a strategic asset, and America keeps spending it.

  • Orion heat shield safety concerns not fully resolved

    Orion's heat shield eroded in an unexpected pattern during Artemis I return. NASA deemed it an acceptable risk after a risk assessment meeting, but this doesn't mean the problem was fully solved. The phrase acceptable risk with four lives at stake is inherently unsettling.

  • Artemis Accords missing China, Russia, and India

    Despite 55 signatories, the accord lacks China (primary competitor), Russia (ILRS co-builder), and India (fastest-rising space power). Whether an incomplete international agreement can prevent lunar resource disputes without these key players is questionable.

Outlook

In the short term, what matters most is whether the April 1 launch actually happens. The March 20 rollout must succeed, and final checks at the pad must pass. The launch window runs April 1-6. I believe the launch will happen this time — the helium issue has been fixed and the rollout schedule is concrete. That said, weather or technical issues could push it a day or two to April 2-6.

If the mission succeeds, Artemis III preparations will accelerate dramatically within the next 6-12 months. Since Artemis III is the actual landing mission with SpaceX Starship as the lander, it marks the true beginning of public-private lunar exploration. I expect Artemis III by 2028, though slightly behind NASA's official timeline, as SpaceX needs more time to perfect Starship's orbital refueling technology.

Looking at 2028-2030, this becomes the decisive period for the US-China lunar competition. If China succeeds with a crewed landing by 2030, the psychological impact will be enormous even if America has already sent people to lunar orbit. If China begins ILRS Phase 1 construction simultaneously, the real competition for South Pole resource access begins. This is when the Artemis Accords face their true test — will those 55 signatures remain paper promises, or function as actual resource-sharing mechanisms?

Looking further out to 2030-2035, the Moon transitions from an exploration target to infrastructure. Permanent bases at the South Pole, hydrogen and oxygen fuel extracted from water ice, refueling stations for Mars-bound spacecraft — these scenarios could become reality. I predict at least two permanently operated bases on the lunar surface by 2035: one US-led, one China-led.

In the best-case scenario, US-China competition accelerates technological progress, both sides successfully operate lunar bases, and some international cooperation on Mars exploration eventually emerges. In the baseline scenario, the US lands first through Artemis but widening mission intervals due to costs allow China to steadily catch up, with both nations maintaining small outposts by the early 2030s. In the worst case, Artemis funding gets cut by Congress, the gap between SLS retirement and replacement vehicle readiness stalls America's lunar program, and China pulls ahead.

One thing is certain across all scenarios: Artemis II is a starting line, not a finish line. If these 10 days of flight succeed, humanity is ready to walk on the Moon again. If they fail? Well, $93 billion becomes an April Fools' joke. But I'm betting on success. After 53 years of waiting, it's time to prove the wait was worth it.

Sources / References

Related Perspectives

Science

The "Harmless Passenger" Virus — Nature Just Questioned That Name

A landmark multi-omics study of 1,154 hospitalized COVID-19 patients across approximately 20 hospitals and 15 research centers in the United States, published in Nature on August 5, 2026, documented significant reactivation of at least 11 latent viruses during acute SARS-CoV-2 infection — including members of the Herpesviridae and Anelloviridae families — within 40 days of hospital admission. The IMPACC cohort study analyzed over 200,000 biological samples and more than 1 billion data points through simultaneous genomic, proteomic, metabolomic, and immunological profiling, making it one of the largest and most methodologically comprehensive infectious-disease datasets ever assembled. Among the reactivating viruses, anelloviruses — carried by roughly 90% of the human population and historically classified as harmless, disease-free passengers — showed a statistically significant association with subsequent long COVID development and long-term physical impairment. The authors themselves explicitly stated: "Although our results do not establish causation between virus reactivation and clinical outcomes," the data nonetheless open a new door toward predictive biomarkers and a reconceptualization of long COVID's underlying mechanism. Arriving in a moment when an estimated 400 million people worldwide have experienced long COVID with no FDA-approved specific treatment available, this paper offers a significant — and long-overdue — directional signal about where the research compass may need to point next.

Science

For a Hundred Years We Carved Space. In Dresden, They Just Carved Time for the First Time.

The world's first all-optical photonic time crystal in the terahertz frequency range was experimentally realized in late July 2026 and published in Nature under the title "Plasmonic metamaterial time crystal," by an international team from École Polytechnique, Collège de France, and Germany's Helmholtz-Zentrum Dresden-Rossendorf (HZDR). The research team constructed a plasmonic metasurface of gold nanostripes on indium antimonide (InSb) semiconductor and, using the TELBE superradiant terahertz source inside HZDR's ELBE accelerator, drove periodic modulation of the material's optical properties on picosecond (one trillionth of a second, 10⁻¹²) timescales at near-unity modulation depths — achieving a regime that had eluded experimentalists for over a decade. In the resulting photonic time crystal (PTC) regime, non-radiative plasmonic losses were reduced by more than 50%, a counterintuitive result in which increasing the drive intensity paradoxically decreases energy losses, mediated by an exceptional point where two Floquet-driven optical eigenmodes coalesce. This discovery adds "time" as a genuinely new active design dimension to a field that for a century relied exclusively on spatial engineering — lenses, fiber optics, photonic crystals, and semiconductor circuits are all, without exception, spatial structures — representing a conceptual expansion of the design space itself rather than merely an improvement of existing components. While the team acknowledged "severe experimental challenges" in their paper and while historical parallels with high-temperature superconductors and laser physics suggest the gap from proof-of-principle to practical application can span decades, the experiment's significance is unambiguous: for the first time, time itself has been added to the toolkit for controlling light.

Science

What We Found on LHS 1140b Isn't Life — It's a 3-Billion-Year Mystery

LHS 1140b, a rocky super-Earth orbiting within the habitable zone of an M dwarf star 48 light-years away, became the first such world to show confirmed atmospheric signals when the WINERED spectrograph mounted on the Magellan Clay telescope at Las Campanas Observatory detected escaping helium in 2024 observations. The study, led by Collin Cherubim of Harvard and co-authored by David Charbonneau, Robin Wordsworth, Jason Dittmann, and Shreyas Vissapragada, was published in Science on July 16, 2026 under DOI 10.1126/science.aea9708. What most media coverage missed is that the genuinely remarkable finding is not the detection itself but the inference that this helium has been actively escaping for more than three billion years while remaining present — meaning something inside the planet must be continuously replenishing it. Co-author Jason Dittmann was explicit about the fundamental ambiguity at the heart of this discovery, asking openly whether the planet hosts a genuine steady-state atmosphere or is simply a bare rock that occasionally burps geological gas that immediately escapes into space. The helium signal detected in 2024 was not replicated in 2025 observations, creating a variability problem that complicates interpretation in ways that confident headline language did not reflect. This discovery does not mark the dawn of evidence for extraterrestrial life; it opens a far more fascinating scientific puzzle about how a rocky planet can sustain an escaping atmosphere across geological time, and what that implies for the billions of M-dwarf habitable-zone planets throughout our galaxy.

Science

India: $15/Month Anti-Aging Shot. U.S.: $1,027 — Insurance Denied. The Paradox Ozempic's Patent Cliff Created.

The first randomized controlled trial demonstrating that semaglutide slows epigenetic aging — with PCGrimAge declining by 3.08 years, PhenoAge by 4.90 years, and DunedinPACE by 9% — was published in Nature Communications, yet the study carries inescapable limitations: 84 HIV-associated lipodystrophy patients, a 32-week window, and aging measurements added as a post-hoc endpoint rather than the trial's primary objective. Lead author Michael Corley explicitly stated, "We are not saying that semaglutide reverses aging or makes people younger" — a caveat stripped from media headlines that instead proclaimed a 3.1-year biological age reversal. The divergence across three clocks — from 3.08 to 4.90 years of apparent benefit — itself exposes the interpretive limits of epigenetic timing tools, which capture population-level statistical associations rather than individual causal mechanisms. Far more transformative than this single study, however, is what happened on March 20, 2026: India's core semaglutide patent (IN 262697) expired, unleashing more than 55 generic brands at prices as low as ₹1,290 per month (~$15), while the United States maintains brand exclusivity through 2031–2036 at $1,027/month with Medicare obesity coverage legally excluded by a 2003 law. For the first time in biomedical history, the benefits of a major pharmaceutical innovation are reaching scale in a developing nation before they are broadly accessible to citizens of the country that built the regulatory system enabling that innovation — a structural reversal that mirrors Cipla's 2001 HIV drug revolution, which expanded African patient access from 8,000 to 12 million people.

Science

We "Solved" Ebola. That Illusion Is Now Killing 700 People in Congo.

The 2026 Ebola outbreak in the Democratic Republic of Congo, driven by Bundibugyo ebolavirus rather than the better-known Zaire strain, has recorded 1,963 confirmed cases and 719 deaths as of mid-July, making it the largest non-Zaire Ebola event in recorded history. Every licensed medical countermeasure — Ervebo, Inmazeb, and Ebanga — was engineered exclusively against Zaire ebolavirus, and a 2026 CDC study confirmed that cross-reactive antibody titers against Bundibugyo fall 73% lower than Zaire-specific responses, prompting WHO to explicitly prohibit Ervebo's programmatic use against this species. Nineteen years elapsed between Bundibugyo's first confirmed emergence in Uganda in 2007 and this outbreak, and during that entire period no species-specific vaccine, therapeutic, or rapid diagnostic test was developed — a direct consequence of the pathogen's rarity eliminating commercial investment incentives. WHO declared a Public Health Emergency of International Concern on May 17, 2026, yet the sole available control tools remain isolation, contact tracing, and safe burial, the same non-pharmacological measures used since 1976. This outbreak constitutes a systemic indictment of a global R&D incentive structure that prices human lives against commercial viability, and of the structural illusion that defeating one ebolavirus species constitutes preparedness against the entire genus.

SimNabuleo AI

AI Riffs on the World — AI perspectives at your fingertips

simcreatio [email protected]

Content on this site is based on AI analysis and is reviewed and processed by people, though some inaccuracies may occur.

© 2026 simcreatio(심크리티오), JAEKYEONG SIM(심재경)

enko